Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.

• Váldodahkkit: Sharon J Peacock (Dahkki), Direk Limmathurotsakul (Dahkki), Yoel Lubell (Dahkki), Gavin C K W Koh (Dahkki), Lisa J White (Dahkki), Nicholas P J Day (Dahkki), Richard W Titball (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Burkholderia pseudomallei is a Category B select agent and the cause of melioidosis. Research funding for vaccine development has largely considered protection within the biothreat context, but the resulting vaccines could be applicable to populations who are at risk of naturally acquired melioidosi...